Novartis | Zobowiązania Handlowe



Trade Creditors Zmiana Data
AbbVie 2.94B 2.66B 2024-12
Alcon AG USD 773M 76M 2024-12
Almirall EUR 182.33M 88.28M 2024-06
Amgen USD 1.91B 239M 2024-12
AstraZeneca 22.46B 781M 2024-12
Autolus Therapeutics Ltd 1.42M 320K 2024-09
Bayer EUR 7.52B 957M 2024-12
Biogen USD 424.2M 1.5M 2024-12
Bristol-Myers Squibb USD 3.6B 133M 2024-12
Eli Lilly USD 3.23B 342.1M 2024-12
Fresenius EUR 1.36B 139M 2024-12
Fresenius Medical Care EUR 904M 132M 2024-12
Galapagos EUR 98.88M 16.98M 2024-12
Gilead Sciences USD 833M 70M 2024-12
GlaxoSmithKline 15.34B 960M 2024-12
GRIFOLS EUR 852.3M 25.42M 2024-12
Hikma Pharmaceutical USD 541M 232M 2024-06
J&J USD 10.31B 1.36B 2024-12
Lonza CHF 468M 9M 2023-12
Merck EUR 1.95B 172M 2024-09
Merck USD 4.08B 493M 2024-12
Novartis USD 4.57B 485M 2024-12
Novartis USD 4.57B 485M 2024-12
Novo Nordisk 24.08B 5.68B 2024-09
Orion EUR 87.1M 9.5M 2024-12
Pfizer USD 5.63B 319M 2024-12
Philips EUR 1.83B 20M 2024-12
Recordati EUR 276.91M 13.26M 2024-09
Regeneron Pharmaceuticals USD 4.89B 4.39B 2024-12
Roche Holding 4.35B 828M 2024-12
Sanofi 7.43B 105M 2024-06
UCB 750M 1.66B 2024-12



Novartis Zobowiązania Handlowe - Aktualne wartości, dane historyczne, prognozy, statystyki, wykresy i kalendarz ekonomiczny - Mar 2025.